<!-- Generated by pkgdown: do not edit by hand -->
<!DOCTYPE html>
<html lang="en">
  <head>
  <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1.0">

<title>AIDS Clinical Trials Group Study 175 — ACTG175 • rerandR</title>

<!-- jquery -->
<script src="https://cdnjs.cloudflare.com/ajax/libs/jquery/3.3.1/jquery.min.js" integrity="sha256-FgpCb/KJQlLNfOu91ta32o/NMZxltwRo8QtmkMRdAu8=" crossorigin="anonymous"></script>
<!-- Bootstrap -->

<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/3.3.7/css/bootstrap.min.css" integrity="sha256-916EbMg70RQy9LHiGkXzG8hSg9EdNy97GazNG/aiY1w=" crossorigin="anonymous" />
<script src="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/3.3.7/js/bootstrap.min.js" integrity="sha256-U5ZEeKfGNOja007MMD3YBI0A3OSZOQbeG6z2f2Y0hu8=" crossorigin="anonymous"></script>

<!-- Font Awesome icons -->
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/4.7.0/css/font-awesome.min.css" integrity="sha256-eZrrJcwDc/3uDhsdt61sL2oOBY362qM3lon1gyExkL0=" crossorigin="anonymous" />

<!-- clipboard.js -->
<script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.4/clipboard.min.js" integrity="sha256-FiZwavyI2V6+EXO1U+xzLG3IKldpiTFf3153ea9zikQ=" crossorigin="anonymous"></script>

<!-- sticky kit -->
<script src="https://cdnjs.cloudflare.com/ajax/libs/sticky-kit/1.1.3/sticky-kit.min.js" integrity="sha256-c4Rlo1ZozqTPE2RLuvbusY3+SU1pQaJC0TjuhygMipw=" crossorigin="anonymous"></script>

<!-- pkgdown -->
<link href="../pkgdown.css" rel="stylesheet">
<script src="../pkgdown.js"></script>



<meta property="og:title" content="AIDS Clinical Trials Group Study 175 — ACTG175" />

<meta property="og:description" content="ACTG 175 was a randomized clinical trial to compare monotherapy with zidovudine or didanosine with combination therapy with zidovudine and didanosine or zidovudine and zalcitabine in adults infected with the human immunodeficiency virus type I whose CD4 T cell counts were between 200 and 500 per cubic millimeter. Only two of the study arms are included in this practice dataset." />
<meta name="twitter:card" content="summary" />



<!-- mathjax -->
<script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js" integrity="sha256-nvJJv9wWKEm88qvoQl9ekL2J+k/RWIsaSScxxlsrv8k=" crossorigin="anonymous"></script>
<script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/config/TeX-AMS-MML_HTMLorMML.js" integrity="sha256-84DKXVJXs0/F8OTMzX4UR909+jtl4G7SPypPavF+GfA=" crossorigin="anonymous"></script>

<!--[if lt IE 9]>
<script src="https://oss.maxcdn.com/html5shiv/3.7.3/html5shiv.min.js"></script>
<script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
<![endif]-->


  </head>

  <body>
    <div class="container template-reference-topic">
      <header>
      <div class="navbar navbar-default navbar-fixed-top" role="navigation">
  <div class="container">
    <div class="navbar-header">
      <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#navbar" aria-expanded="false">
        <span class="sr-only">Toggle navigation</span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      <span class="navbar-brand">
        <a class="navbar-link" href="../index.html">rerandR</a>
        <span class="version label label-default" data-toggle="tooltip" data-placement="bottom" title="Released version">0.0.1.9999</span>
      </span>
    </div>

    <div id="navbar" class="navbar-collapse collapse">
      <ul class="nav navbar-nav">
        <li>
  <a href="../index.html">
    <span class="fa fa-home fa-lg"></span>
     
  </a>
</li>
<li>
  <a href="../reference/index.html">Reference</a>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-expanded="false">
    Articles
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="../articles/01-mahalanobis.html">rerandR: mahalanobis distance</a>
    </li>
    <li>
      <a href="../articles/02-rerand.html">rerandR: Re-randomization approach</a>
    </li>
  </ul>
</li>
<li>
  <a href="../news/index.html">Changelog</a>
</li>
      </ul>
      
      <ul class="nav navbar-nav navbar-right">
        <li>
  <a href="https://github.com/kmcconeghy/rerandR">
    <span class="fa fa-github fa-lg"></span>
     
  </a>
</li>
      </ul>
      
    </div><!--/.nav-collapse -->
  </div><!--/.container -->
</div><!--/.navbar -->

      
      </header>

<div class="row">
  <div class="col-md-9 contents">
    <div class="page-header">
    <h1>AIDS Clinical Trials Group Study 175</h1>
    <small class="dont-index">Source: <a href='https://github.com/kmcconeghy/rerandR/blob/master/R/ACTG175.R'><code>R/ACTG175.R</code></a></small>
    <div class="hidden name"><code>ACTG175.Rd</code></div>
    </div>

    <div class="ref-description">
    
    <p>ACTG 175 was a randomized clinical trial to compare monotherapy with zidovudine or didanosine with combination therapy with zidovudine and didanosine or zidovudine and zalcitabine in adults infected with the human immunodeficiency virus type I whose CD4 T cell counts were between 200 and 500 per cubic millimeter. Only two of the study arms are included in this practice dataset.</p>
    
    </div>

    <pre class="usage"><span class='fu'><a href='https://www.rdocumentation.org/packages/utils/topics/data'>data</a></span>(<span class='no'>ACTG175</span>)</pre>
        
    <h2 class="hasAnchor" id="format"><a class="anchor" href="#format"></a>Format</h2>

    <p>A data frame with 2139 rows and 27 variables:</p>
<dl class='dl-horizontal'>
<dt>pidnum</dt><dd><p>patient's ID number</p></dd>
<dt>age</dt><dd><p>age in years at baseline</p></dd>
<dt>wtkg</dt><dd><p>weight in kg at baseline</p></dd>
<dt>hemo</dt><dd><p>hemophilia (0=no, 1=yes)</p></dd>
<dt>msm</dt><dd><p>Men who have sex with men (0=no, 1=yes)</p></dd>
<dt>drugs</dt><dd><p>history of intravenous drug use (0=no, 1=yes)</p></dd>
<dt>karnof</dt><dd><p>Karnofsky score (on a scale of 0-100)</p></dd>
<dt>oprior</dt><dd><p>non-zidovudine antiretroviral therapy prior to initiation of study treatment (0=no, 1=yes)</p></dd>
<dt>z30</dt><dd><p>zidovudine use in the 30 days prior to treatment initiation (0=no, 1=yes)</p></dd>
<dt>zprior</dt><dd><p>zidovudine use prior to treatment initiation (0=no, 1=yes)</p></dd>
<dt>preanti</dt><dd><p>number of days of previously received antiretroviral therapy</p></dd>
<dt>race</dt><dd><p>race (0=white, 1=non-white)</p></dd>
<dt>gender</dt><dd><p>gender (0=female, 1=male)</p></dd>
<dt>str2</dt><dd><p>antiretroviral history (0=naive, 1=experienced)</p></dd>
<dt>strat</dt><dd><p>antiretroviral history stratification (1='antiretroviral naive', 2='&gt; 1 but ≤q 52 weeks of prior antiretroviral therapy', 3='&gt; 52 weeks')</p></dd>
<dt>symptom</dt><dd><p>symptomatic indicator (0=asymptomatic, 1=symptomatic)</p></dd>
<dt>treat</dt><dd><p>treatment indicator (0=zidovudine only, 1=other therapies)</p></dd>
<dt>offtrt</dt><dd><p>indicator of off-treatment before 965 weeks (0=no,1=yes)</p></dd>
<dt>cd40</dt><dd><p>CD4 T cell count at baseline</p></dd>
<dt>cd420</dt><dd><p>CD4 T cell count at 205 weeks</p></dd>
<dt>cd496</dt><dd><p>CD4 T cell count at 965 weeks (=NA if missing)</p></dd>
<dt>r</dt><dd><p>missing CD4 T cell count at 965 weeks (0=missing, 1=observed)</p></dd>
<dt>cd80</dt><dd><p>CD8 T cell count at baseline</p></dd>
<dt>cd820</dt><dd><p>CD8 T cell count at 20 weeks</p></dd>
<dt>cens</dt><dd><p>indicator of observing the event in days</p></dd>
<dt>days</dt><dd><p>number of days until the first occurrence of: (i) a decline in CD4 T cell count of at least 50 (ii) an event indicating progression to AIDS, or (iii) death.</p></dd>
<dt>arms</dt><dd><p>treatment arm (0=zidovudine, 1=zidovudine and didanosine, 2=zidovudine and zalcitabine, 3=didanosine)</p></dd>
</dl>
    
    <h2 class="hasAnchor" id="source"><a class="anchor" href="#source"></a>Source</h2>

    <p><a href='https://cran.r-project.org/web/packages/speff2trial/index.html'>https://cran.r-project.org/web/packages/speff2trial/index.html</a></p>
    
    <h2 class="hasAnchor" id="details"><a class="anchor" href="#details"></a>Details</h2>

    <p>The variable days contains right-censored time-to-event observations. The data set includes the following post-randomization covariates: CD4 and CD8 T cell count at 205 weeks and the indicator of whether or not the patient was taken off-treatment before 965 weeks.</p>
    
    <h2 class="hasAnchor" id="references"><a class="anchor" href="#references"></a>References</h2>

    <p>Hammer SM, et al. (1996), "A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter.", New England Journal of Medicine, 335: 1081 – 1090.</p>
    

  </div>
  <div class="col-md-3 hidden-xs hidden-sm" id="sidebar">
    <h2>Contents</h2>
    <ul class="nav nav-pills nav-stacked">
      
      <li><a href="#format">Format</a></li>

      <li><a href="#source">Source</a></li>

      <li><a href="#details">Details</a></li>

      <li><a href="#references">References</a></li>
          </ul>

  </div>
</div>

      <footer>
      <div class="copyright">
  <p>Developed by Kevin W. McConeghy.</p>
</div>

<div class="pkgdown">
  <p>Site built with <a href="https://pkgdown.r-lib.org/">pkgdown</a> 1.3.0.</p>
</div>
      </footer>
   </div>

  

  </body>
</html>

